Draft genome sequences of sp. MMG031 and sp. MMG032 isolated from the dinoflagellate .

Here, we report the draft genome sequences of sp. MMG031 and sp. MMG032, isolated from coral-associated dinoflagellate , assembled and analyzed by undergraduate students participating in a Marine Microbial Genomics (MMG) course.

Australian outcomes from heart transplantation in the machine perfusion era.

Background: In the current era of heart transplantation, machine perfusion strategies are emerging as potential additions to the armamentarium of a transplant unit. Donation after circulatory death (DCD) donor hearts assessed through normothermic machine perfusion (NMP) has helped expand the donor pool. Hypothermic machine perfusion (HMP) is emerging as an alternative strategy to traditional static cold storage (SCS) when a prolonged ischemic time is anticipated in brain dead (BD) donors, this is important in Australia where long distant procurement is vital.

Evidence gaps in orthognathic surgery: an international Delphi study.

The aim of this study was to assess the evidence gaps identified in a recent mapping review of orthognathic surgery by evaluating them through consultation with maxillofacial surgeons. Using the Delphi technique, a panel of surgeons who regularly perform orthognathic surgery was engaged. Potential participants were identified through articles included in the mapping review, peer nominations, and social media platforms .

Successful Collaborations that Resulted in Increased U.S. Diagnostic Testing During the 2022 Mpox Outbreak.

Context: The first case of mpox was detected in the United States in a Laboratory Response Network (LRN) laboratory at the Massachusetts Department of Public Health on May 17, 2022. Through previous years of smallpox preparedness efforts by the United States government, testing capacity in LRN laboratories across the United States utilizing the FDA-cleared Centers for Disease Control and Prevention (CDC) Non-variola orthopoxvirus (NVO) test was approximately 6000 tests weekly across the nation prior to the mpox outbreak. By early June 2022, the LRN laboratories had capacity to perform up to 8000 tests per week.